MedPath

Viralclear Pharmaceuticals, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)โ€ข Click on a phase to view related trials

Phase 2
1 (100.0%)

Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19

Phase 2
Terminated
Conditions
COVID-19
Interventions
Drug: Matching Placebo
First Posted Date
2020-06-01
Last Posted Date
2020-12-08
Lead Sponsor
ViralClear Pharmaceuticals, Inc.
Target Recruit Count
44
Registration Number
NCT04410354
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic in Arizona, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Holy Cross Hospital, Fort Lauderdale, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic in Florida, Jacksonville, Florida, United States

and more 7 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.